Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-19

FDA Approved: DUOPA — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

The FDA approved a supplemental application for DUOPA (carbidopa and levodopa) filed by AbbVie Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DUOPA (Carbidopa and Levodopa)

Snippet

SUPPL AP for DUOPA (CARBIDOPA AND LEVODOPA)